GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » Net Margin %

Turk Ilac ve Serumnayi (IST:TRILC) Net Margin % : 13.50% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Turk Ilac ve Serumnayi's Net Income for the three months ended in Sep. 2023 was ₺59 Mil. Turk Ilac ve Serumnayi's Revenue for the three months ended in Sep. 2023 was ₺436 Mil. Therefore, Turk Ilac ve Serumnayi's net margin for the quarter that ended in Sep. 2023 was 13.50%.

The historical rank and industry rank for Turk Ilac ve Serumnayi's Net Margin % or its related term are showing as below:

IST:TRILC' s Net Margin % Range Over the Past 10 Years
Min: 5.52   Med: 11.83   Max: 16.71
Current: 8.52


IST:TRILC's Net Margin % is ranked better than
65.59% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.225 vs IST:TRILC: 8.52

Turk Ilac ve Serumnayi Net Margin % Historical Data

The historical data trend for Turk Ilac ve Serumnayi's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turk Ilac ve Serumnayi Net Margin % Chart

Turk Ilac ve Serumnayi Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial 14.79 8.86 16.71 5.52 7.96

Turk Ilac ve Serumnayi Quarterly Data
Dec17 Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.23 4.81 2.66 10.16 13.50

Competitive Comparison of Turk Ilac ve Serumnayi's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turk Ilac ve Serumnayi's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's Net Margin % distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's Net Margin % falls into.



Turk Ilac ve Serumnayi Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Turk Ilac ve Serumnayi's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=66.377/833.438
=7.96 %

Turk Ilac ve Serumnayi's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=58.831/435.882
=13.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turk Ilac ve Serumnayi  (IST:TRILC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Turk Ilac ve Serumnayi Net Margin % Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750
Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines